Discouraging inappropriate antibiotic use will require changing how patients and physicians are reimbursed for antibiotic prescriptions, and how physicians are paid for prescribing them.
Antibiotic resistance stems from insufficient incentives for patients, physicians, hospitals, and drug companies to do the right thing.
Dates of Project: May 2005 to December 2011
Field of Work: Antibiotic resistance
Problem Synopsis: Modern medicine depends on antibiotics to control bacterial infections, but pathogens resistant to antibiotics have emerged and spread rapidly. The Institute of Medicine and many others have sounded urgent calls to address this growing threat, yet policy-makers have done little to respond.
Synopsis of the Work: Extending the Cure researchers evaluated antibiotics and resistance of them, and proposed incentives to make the best use of existing antibiotics and encourage the discovery of new ones. The researchers framed the problem as one of “the commons”: antibiotics are a shared resource like clean air and safe drinking water, and any use of these drugs diminishes their overall effectiveness.
Key Results: Extending the Cure researchers:
- Published Extending the Cure: Policy Responses to the Growing Threat of Antibiotic Resistance, which concludes that patients, physicians, hospitals, and drug companies have insufficient incentives to conserve the effectiveness of existing antibiotics. What is good for each patient and entity conflicts with what is good for society.
- Published 23 journal articles, and 13 policy briefs on antibiotic resistance and potential responses.
- Launched the Drug Resistance Index, which tracks the resistance of microbes that cause common diseases, based on their resistance to individual drugs and the frequency with which clinicians prescribe them.
- Developed the ResistanceMap, which shows changes in antibiotic use and the resistance of microbes to individual drugs across North America and Europe.
Related antibiotics create cross-resistance, so each drug company has little incentive to consider resistance if other firms are selling similar drugs.
#Superbugs. Public stewardship of antibiotics essential to wise use by docs, drug cos., and patients.
While the need to address disparities in care is well known, few strategies for reducing disparities have been studied systematically.
RWJF examines the types of competitive foods - foods and beverages schools offer outside of meal programs - available in our nation's school...
"The light at the end of the tunnel is ... that I carried the struggle further, and that I taught my children correctly, in the way they cho...
In 1990, Dr. Hotz's focus on collaboration led to the creation of another nonprofit organization designed to coordinate public and private h...
To Dr. Cheryl Holder, success lies in "…understanding the needs of my community and how to make solutions happen."
"I remember Ronald's smile and upbeat attitude about everything. No matter how despairing and hopeless I felt (I was clinically depressed) h...
To Dr. Arlene Goldsmith, anyone can become a leader, provided they are driven, have a personality that is open and engaging, and a passionat...
Whatever I learn from those experiences, I pass on to the people around me, so they don't have to go through what I went through in order to...
Since winning the award, Dr. Bonds has expanded her health-related educational programs, particularly through the increased use of technolog...
"Being a volunteer tests you, to see if you really can make a difference and if you really want to do it - because you do have to make sacri...
"Mr. Chatman will always be in my heart and mind. He taught me to love myself and others. He gave me a chance when no one else would."
The way Mr. Lynch looks at it, anyone can be a leader - with mentoring, training, and the right opportunity (the chance to make a living doi...